• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implications of comorbidities in nonalcoholic fatty liver disease.

作者信息

Song Sherlot Juan, Wong Vincent Wai-Sun

机构信息

Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Clin Mol Hepatol. 2023 Apr;29(2):384-389. doi: 10.3350/cmh.2023.0066. Epub 2023 Mar 14.

DOI:10.3350/cmh.2023.0066
PMID:36916170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121281/
Abstract
摘要

相似文献

1
Implications of comorbidities in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中共病的影响
Clin Mol Hepatol. 2023 Apr;29(2):384-389. doi: 10.3350/cmh.2023.0066. Epub 2023 Mar 14.
2
An update on nonalcoholic fatty liver disease.非酒精性脂肪性肝病的最新进展。
JAAPA. 2014 Jul;27(7):18-22. doi: 10.1097/01.JAA.0000450801.19545.93.
3
Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese.糖尿病和胰岛素对病态肥胖患者非酒精性脂肪肝的影响。
Ann Hepatol. 2018;17(4):585-591. doi: 10.5604/01.3001.0012.0922.
4
Obstructive sleep apnea and severity of nonalcoholic fatty liver disease.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2021 Aug 1;33(8):1104-1109. doi: 10.1097/MEG.0000000000001920.
5
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者风险分层中使用的无创性检查。
Clin Liver Dis. 2023 May;27(2):373-395. doi: 10.1016/j.cld.2023.01.022. Epub 2023 Mar 8.
6
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
7
Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients.1型糖尿病患者的肥胖与非酒精性脂肪性肝病
J Diabetes Complications. 2022 Dec;36(12):108359. doi: 10.1016/j.jdiacomp.2022.108359. Epub 2022 Nov 24.
8
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.非酒精性脂肪性肝病与心血管病：重叠的发病机制。
Semin Liver Dis. 2021 Aug;41(3):235-247. doi: 10.1055/s-0041-1725022. Epub 2021 May 15.
9
Nonalcoholic Fatty Liver Disease: A Unique Entity or Part of the Metabolic Syndrome or Both.非酒精性脂肪性肝病：一种独特的疾病实体，还是代谢综合征的一部分，抑或是两者皆是？
Med Clin North Am. 2023 May;107(3):449-463. doi: 10.1016/j.mcna.2022.12.003. Epub 2023 Feb 20.
10
Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital.非酒精性脂肪性肝病的流行率和严重程度在临床实践中被低估：在一家大型大学教学医院采用专门的筛查方法的影响。
Diabet Med. 2018 Jan;35(1):89-98. doi: 10.1111/dme.13540.

引用本文的文献

1
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis.减重干预可改善肥胖患者代谢功能障碍相关脂肪性肝炎：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Jul;30(3):561-576. doi: 10.3350/cmh.2023.0384. Epub 2024 Jun 3.

本文引用的文献

1
Nonalcoholic fatty liver disease and non-liver comorbidities.非酒精性脂肪性肝病与非肝脏合并症。
Clin Mol Hepatol. 2023 Feb;29(Suppl):s86-s102. doi: 10.3350/cmh.2022.0442. Epub 2023 Jan 5.
2
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.一项关于 2 型糖尿病患者非酒精性脂肪性肝病、肝纤维化、肝硬化和肝细胞癌患病率的前瞻性研究。
J Hepatol. 2023 Mar;78(3):471-478. doi: 10.1016/j.jhep.2022.11.010. Epub 2022 Nov 19.
3
Geographical similarity and differences in the burden and genetic predisposition of NAFLD.非酒精性脂肪性肝病负担及遗传易感性的地理相似性与差异
Hepatology. 2023 Apr 1;77(4):1404-1427. doi: 10.1002/hep.32774. Epub 2022 Oct 11.
4
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study.可改变的危险因素与非酒精性脂肪性肝病之间的关联：一项全面的孟德尔随机化研究。
Hepatology. 2023 Mar 1;77(3):949-964. doi: 10.1002/hep.32728. Epub 2023 Feb 17.
5
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.年龄与非酒精性脂肪性肝病中与肝脏相关的死亡的相对重要性。
Hepatology. 2023 Feb 1;77(2):573-584. doi: 10.1002/hep.32633. Epub 2022 Jul 15.
6
Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study.非酒精性脂肪性肝病与心血管疾病：一项孟德尔随机化研究。
Metabolism. 2022 Aug;133:155220. doi: 10.1016/j.metabol.2022.155220. Epub 2022 May 23.
7
Non-alcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes.非酒精性脂肪性肝病、睡眠行为与 2 型糖尿病发病风险。
J Gastroenterol Hepatol. 2022 Aug;37(8):1633-1640. doi: 10.1111/jgh.15877. Epub 2022 May 10.
8
Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.非酒精性脂肪性肝病与冠状动脉疾病的关系：一项孟德尔随机化研究。
Hepatology. 2023 Jan 1;77(1):230-238. doi: 10.1002/hep.32534. Epub 2022 May 18.
9
Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease.糖尿病合并非酒精性脂肪性肝病患者中，按年龄和糖尿病病程划分的肝脏相关事件风险。
Hepatology. 2022 Nov;76(5):1409-1422. doi: 10.1002/hep.32476. Epub 2022 Apr 7.
10
Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study.非酒精性脂肪肝疾病与中风：一项孟德尔随机化研究。
Eur J Neurol. 2022 May;29(5):1534-1537. doi: 10.1111/ene.15277. Epub 2022 Feb 20.